POT1 | Protection of telomeres 1 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
PTEN | Phosphatase and tensin homolog | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
RAD21 | RAD21 homolog (S. pombe) | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
RB1 | Retinoblastoma 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
RECQL4 | RecQ protein-like 4 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
RET | Ret proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
RPL5 | Ribosomal protein L5 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Ribosomal proteins
| | | | | Expressed in all |
SDHB | Succinate dehydrogenase complex, subunit B, iron sulfur (Ip) | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
STK11 | Serine/threonine kinase 11 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
TET2 | Tet methylcytosine dioxygenase 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Mixed |
TP53 | Tumor protein p53 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transcription factors Transporters
| | | | | Expressed in all |
TSC1 | Tuberous sclerosis 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
TSC2 | Tuberous sclerosis 2 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
UBR5 | Ubiquitin protein ligase E3 component n-recognin 5 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
VHL | Von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
WAS | Wiskott-Aldrich syndrome | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
WRN | Werner syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Mixed |
XPA | Xeroderma pigmentosum, complementation group A | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
XPC | Xeroderma pigmentosum, complementation group C | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |